PREVALENCE AND CORRELATION OF METABOLIC SYNDROME IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

Background: Chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MetS) are prevalent chronic conditions with significant impacts on public health. Despite evidence suggesting a bidirectional relationship between COPD and MetS, data on the prevalence and correlation of MetS in COPD patients remain limited.This cross-sectional study aimed to investigate the prevalence of MetS in COPD patients admitted at Rural Medical College Loni and explore its correlation. Methods: A total of 50 COPD patients aged 40 years and above were recruited. Demographic and clinical data were collected through face-to-face interviews and medical record review. Diagnosis ofMetS was done based on the International Diabetes Federation criteria. Logistic regression analysis was performed to identify factors associated with MetS in COPD patients. Results: The mean age of the study population was 60.92 ± 8.97 years, with 76% being male. The prevalence of MetS among COPD patients was42%. The majority of patients with MetS exhibited grade 3 dyspnea based on modified medical research council grading (MMRC). MetS was most prevalent among patients with GOLD stage III disease. Conclusion: Metabolic syndrome is highly prevalent among COPD patientsadmitted at Rural Medical College Loni andpatients with MetS present with more severe disease and frequent exacerbations. Identification of MetS in COPD patients is crucial for comprehensive disease management and warrants integrated care approaches targeting both respiratory and metabolic health. Further research is needed to elucidate the underlying mechanisms linking COPD and MetS and develop tailored interventions to improve outcomes in this population.